Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Interleukin Companies

ID: MRFR/HC/1971-HCR
200 Pages
Satyendra Maurya
Last Updated: May 15, 2026
Dedicated to advancing medical research, IL-10 Pipeline companies focus on developing therapies harnessing the potential of Interleukin-10. These organizations drive progress in treating inflammatory disorders, autoimmune diseases, and beyond, contributing to the evolution of novel pharmaceuticals with the promise of improved patient outcomes.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Interleukin Market

Interleukin-10 Pipeline Key Companies
 
Latest Interleukin-10 Pipeline Companies Update

AnaptysBio's ANB-038 Phase 2a trial for inflammatory bowel disease (IBD) met primary endpoint: December 2023 success paves the way for further clinical evaluation of ANB-038, a novel engineered IL-10 variant, for treating IBD.

Regeneron's REGN2810 Phase 2 trial for atopic dermatitis (AD) demonstrates positive preliminary data: January 2024 announcement suggests REGN2810's potential in treating AD, with improvements observed in itch and skin lesions.

Janssen Pharmaceutical's IL-10 antibody JNJ-75641378 in a Phase 2 trial for Sjögren's syndrome shows early efficacy: November 2023 development indicates potential for JNJ-75641378 in treating this autoimmune disease affecting salivary and tear glands.

AstraZeneca and Innate Pharma team up for IL-10-based immuno-oncology therapies: December 2023 collaboration combines expertise to develop next-generation IL-10 therapies for cancer treatment.

Roche and Evelo Biosciences partner to discover and develop novel IL-10 agonists: November 2023 collaboration leverages Evelo's AI-powered drug discovery platform to accelerate the development of new IL-10-based treatments.

List of Interleukin-10 Pipeline Key Companies in the Market

  • Pfizer Inc.
  • Merck & Co.Inc
  • Biotest AG
  • BioMAS Ltd
  • EnGene Inc.
  • Leo Pharma
  • Anvil Biosciences
  • Intrexon Corporation
  • P2D Biosciences
  • Xalud Therapeutics INC